A Century of Stock Market Winners; And Why Most Stocks Failed
Hendrik Bessembinder has spent years asking one of the most important and counterintuitive questions in investing: if the stock market […]
May 26, 2026
Micron Stock Price Pops on UBS Call for Shares to Rally 90%
Micron stock surpassed a $1 trillion marker cap on Tuesday, thanks to a rally fueled by UBS’s highly bullish call
Kaiko Says Weekly Spot Volume in Top 10 Crypto Tokens Fell to $80 Billion, Less Than Half of 2025
Kaiko said weekly average spot trading volume in the top 10 cryptocurrencies totaled about $80 billion this year, down to
Micron stock leads chips higher as UBS sees company becoming a $1.8 trillion AI giant
Micron (MU) opened at a record intraday high Tuesday after UBS more than tripled its price target on the memory
Britain Expands Russia Sanctions, Targets Crypto Networks, Uranium Trade
The United Kingdom imposed new sanctions on Russian financial and cryptocurrency networks, targeting mechanisms Moscow is believed to use to
MU Stock Draws Investor Cheer After UBS’ New Price Target Implies 100% Upside From Current Levels – What’s Driving The Analyst Optimism?
The firm believes MU will continue to re-rate higher as more details emerge about the structural changes Al has driven
Police warn of fake AI crypto investment apps after $50m losses in one week
Police have warned that scammers are using false promises of “AI analysis” for cryptocurrency investment and fake mobile apps to
Arm Holdings PLC Stock (ARM) Opened Up by 3.91% on May 26: A Full Analysis
ARM Holdings (ARM) experienced significant upward movement, driven by several favorable factors impacting its financial outlook, industry positioning, and market
Bitget Wallet Expands Real-World Crypto Payments in Emerging Markets on Stellar
SAN SALVADOR, El Salvador, May 26, 2026 (GLOBE NEWSWIRE) — Bitget Wallet, the everyday finance app, is expanding its initiatives
Is Viking Therapeutics (VKTX) Pricing In Too Much Optimism After Recent Share Price Swings?
This article examines whether Viking Therapeutics at US$30.89 is pricing in too much optimism or still offers potential value, by